Business Opportunities

US FDA say GSK vaccine blocks cancer virus

The US Food and Drug Administration says a vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer. - Rest In Peace - JB Chemicals gets USFDA nod for its anti-allergic tablets - Unichem Labs gets USFDA nod for hypertension tablets - GSK to launch "promecta" in India by 2009-end - Ranbaxy receives final USFDA approval for Glycopyrolate - Biomarker to help detect CAD at early stage In documents posted online, the FDA says Cervarix, Glaxo"s vaccine against human papilloma virus or HPV, blocked the virus almost 93% of the time. Side effects with the vaccine were mild, such as soreness at the injection site. Cervarix already is approved in nearly 100 other countries, but has been delayed in the United States since 2007 because the FDA said it needed additional data. The agency will ask a panel of vaccine experts next week whether Cervarix should be approved for girls and women ages 10 to 25.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Bollywood-multiplex stand-off may end before June 12
Millions of fans of Hindi movies will soon be able to watch their favourite Bollywood films in multiplexes, with highly-placed sources in the film production and exhibition business saying a resolution is expected before June 12 to the two-month dispute over revenue-sharing between producers, distributors and multiplex owners.
Popular Articles
payday loan lenders

Future Group to launch more private labels: Biyani
Kishore Biyani-promoted Future Group is expanding its private labels in various categories with plans to launch more products in new segments, such as toothpaste, as part of plans to become a Rs 25,000 crore conglomerate by 2013-14.

Biscuit-makers take on traditional sweets
For most consumer product players in the country, the upcoming festive season is being looked upon as the best platform to return into the black. However, for the biscuit and confectionary makers, the customer preference of traditional sweets over packaged items is expected to affect business. To counter this, companies are devising strategies to hold their profits through gift hampers and customised products.